Recombinant adenovirus-hepatocyte growth factor(Institute Of Radiation And Radiation Medicine, Chinese Academy Of Military Medical Sciences)
N/A
Report date: 2023/02/25 19:25:30
Base Information
Drug NameRecombinant adenovirus-hepatocyte growth factor(Institute Of Radiation And Radiation Medicine, Chinese Academy Of Military Medical Sciences)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesInstitute Of Radiation And Radiation Medicine, Chinese Academy Of Military Medical SciencesBeijing Haitai United Pharmaceutical Technology Development Co Ltd
China Registration ClassN/A
Develop Information
Active CompaniesBeijing Haitai United Pharmaceutical Technology Development Co LtdInstitute Of Radiation And Radiation Medicine, Chinese Academy Of Military Medical Sciences
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A